History and Health Policy in the United States: The Making of a Health Care Industry, 1948-2008

2008 ◽  
Vol 21 (3) ◽  
pp. 461-483 ◽  
Author(s):  
R. A. Stevens
Keyword(s):  
United States ◽  
Health Care ◽  
Health Policy ◽  
Health Care Industry ◽  
The United States ◽  
Care Industry

Antitrust Implications of Health Planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City

1982 ◽  
Vol 8 (3) ◽  
pp. 321-348
Author(s):  
Judy B. Chase
Keyword(s):  
Health Care ◽  
Kansas City ◽  
Health Planning ◽  
United States Supreme Court ◽  
Health Care Industry ◽  
The United States ◽  
United States Supreme ◽  
Planning Activity ◽  
Care Industry ◽  
Antitrust Laws

AbstractIn National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City, the United States Supreme Court held that there is no blanket exemption from antitrust laws for health planning activities.‘The Court also held that no specific immunity can be granted where the challenged health planning activity is not undertaken pursuant to a federal regulatory scheme. This Comment reviews the Court’s decision and concludes that the Court correctly determined that the challenged activities did not qualify for an exemption. The Comment also examines the implications of the Court's statement that, where Congress has manifested a belief that competition is ineffective in the health care industry, application of the antitrust laws should be modified. The Comment recommends that an intermediate review standard such as the “presumptive, incentive modifying approach” should be used by future courts in deciding whether the ineffectiveness of competition in a given area of health planning activity warrants immunity from antitrust scrutiny.

The Ongoing U.S. Health Care Crisis: A Data Update

2018 ◽  
Vol 48 (2) ◽  
pp. 209-222 ◽  
Author(s):  
David U. Himmelstein ◽  
Steffie Woolhandler ◽  
Mark Almberg ◽  
Clare Fauke
Keyword(s):  
United States ◽  
Health Care ◽  
Health Policy ◽  
Medical Care ◽  
Affordable Care Act ◽  
Cost Sharing ◽  
The United States ◽  
Health Care Crisis ◽  
Corporate Takeover ◽  
Data Update

While efforts to repeal the Affordable Care Act were narrowly defeated, grave problems in health care persist. Twenty-eight million remain uninsured, a number that is likely to increase. Millions more who have coverage cannot afford care because of high cost-sharing requirements. Meanwhile, the corporate takeover of medical care in the United States is at a gallop. This article provides a brief précis of recent data on U.S. health policy.

The Costs of Mergers and Acquisitions in the U.S. Health Care Sector

1997 ◽  
Vol 27 (1) ◽  
pp. 77-87 ◽  
Author(s):  
Patrick Bond ◽  
Robert Weissman
Keyword(s):  
Health Care ◽  
Mergers And Acquisitions ◽  
Health Care Industry ◽  
The United States ◽  
Industry Concentration ◽  
Care Industry ◽  
Consumer Concerns ◽  
Pharmaceutical Industries ◽  
Pricing Power ◽  
The U.S

Important trends are emerging from evidence of health care industry concentration in the United States. Some of these are the durable consumer concerns—cost, choice, and access—which have received attention throughout the introduction of managed care. But with the intensified industry concentration, these have been joined by concerns about pricing power, control and quality, integrity of the health system and health policy-making, and clashing institutional mandates. Such trends are particularly evident in the hospital and pharmaceutical industries.

Health Economics: National Health Expenditures

2018 ◽  
Author(s):  
Bruce L Hall
Keyword(s):  
Health Care ◽  
Health Policy ◽  
Health Economics ◽  
National Health ◽  
Opportunity Cost ◽  
Health Care Industry ◽  
Health Expenditures ◽  
Care Industry ◽  
The Us ◽  
And Performance

A picture of the overall structure of the US health care industry can be garnered by examining national health expenditures. In 2015, US national health expenditures grew to $3.2 trillion (US), outpacing growth in gross domestic product. Valuable insights are found by examining categories of spending, sources of funds, and target areas of spending, raising questions about the logic and performance of the US system. These perspectives can inform deeper consideration of healthcare policy and reform. This review contains 3 tables and 20 references. Key Words: health economics, health policy, Medicaid, Medicare, national health expenditures, opportunity cost, projections

Development of Hospice and Palliative Care in the United States

2008 ◽  
Vol 56 (1) ◽  
pp. 89-99 ◽  
Author(s):  
Stephen R. Connor
Keyword(s):  
United States ◽  
Palliative Care ◽  
Health Care Industry ◽  
The United States ◽  
Regulatory Change ◽  
Care Providers ◽  
Care Industry ◽  
History Of ◽  
Hospice And Palliative Care

More than 30 years have passed since palliative care was introduced in the United States, and what began as a small rebellion has evolved into a fairly large health care industry. Although the palliative care movement has considerably improved the care given to those at the end of life, many challenges remain for palliative care providers in the United States. This article discusses the history of hospice and palliative care in the United States, the Medicare Hospice Benefit, the growth of hospice and palliative care, and challenges such as the need for regulatory change, workforce issues, improving access to care, and improving the quality of palliative care.

Health Economics: National Health Expenditures

2018 ◽  
Author(s):  
Bruce L Hall
Keyword(s):  
Health Care ◽  
Health Policy ◽  
Health Economics ◽  
National Health ◽  
Opportunity Cost ◽  
Health Care Industry ◽  
Health Expenditures ◽  
Care Industry ◽  
The Us ◽  
And Performance

A picture of the overall structure of the US health care industry can be garnered by examining national health expenditures. In 2015, US national health expenditures grew to $3.2 trillion (US), outpacing growth in gross domestic product. Valuable insights are found by examining categories of spending, sources of funds, and target areas of spending, raising questions about the logic and performance of the US system. These perspectives can inform deeper consideration of healthcare policy and reform. This review contains 3 tables and 20 references. Key Words: health economics, health policy, Medicaid, Medicare, national health expenditures, opportunity cost, projections

Sign in / Sign up

Export Citation Format

Share Document